IA Interviews: Michael Geranen of Captura Biopharma

by Innovate Arkansas May 29, 2020 Clients

David Sanders, Director of Innovate Arkansas (IA) at Winrock interviews Michael Geranen, CEO of Captura Biopharma about the company’s lead product that acts as a decorporation agent to be given to individuals that have been exposed to radiation, such as may occur in a nuclear power accident or detonation of a “dirty bomb”. This product would be the first oral solution that can immediately be administered to eliminate harmful radioactive material from staying in the body. Learn more about the work that Captura Biopharma is doing at https://www.capturabiopharma.com/

Share this article